Skip to content

Increased use of illicit drugs in a Dutch cluster headache population

Ilse F. de Coo, Willemijn C. Naber, Leopoldine A. Wilbrink, Joost Haan, Michel D. Ferrari, Rolf Fronczek

Cephalalgia October 5, 2018 DOI: 10.1177/0333102418804160 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional study Peer reviewed
Sample size 756
Population People with cluster headache in the Netherlands
Topics Addiction LSD Psilocybin
Keywords Cluster headache Population Illicit drug Heroin Cluster spacecraft Hallucinogen Environmental health Migraine
Citations 47
Key findings People with cluster headache report higher lifetime illicit drug use than the general population, and some users report reductions in attack frequency or duration with psilocybin, LSD, heroin, or amphetamines.

Abstract

Introduction: Many patients with cluster headache report use of illicit drugs. We systematically assessed the use of illicit drugs and their effects in a well-defined Dutch cluster headache population.

Methods: In this cross-sectional explorative study, 756 people with cluster headache received a questionnaire on lifetime use and perceived effects of illicit drugs. Results were compared with age and sex-matched official data from the Dutch general population.

Results: Compared to the data from the general population, there were more illicit drug users in the cluster headache group (31.7% vs. 23.8%; p < 0.01). Reduction in attack frequency was reported by 56% (n = 22) of psilocybin mushroom, 60% (n = 3) of lysergic acid diethylamide and 50% (n = 2) of heroin users, and a decreased attack duration was reported by 46% (n = 18) of PSI, 50% (n = 2) of heroin and 36% (n = 8) of amphetamine users.

Conclusion: In the Netherlands, people with cluster headache use illicit drugs more often than the general population. The question remains whether this is due to an actual alleviatory effect, placebo response, conviction, or common pathophysiological background between cluster headache and addictive behaviours such as drug use.

Comparable studies

Other cross-sectional and survey studies on LSD for addiction, most cited first.

Study Year Design Participants
User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study Users of hallucinogenic drugs who completed a web-based questionnaire 2010 Cross-sectional survey n = 600
Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample Norwegian adults who have had a memorable experience after taking a classic psychedelic... 2023 Cross-sectional survey n = 770
Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice—Lessons Learned from a State Underrepresented in Clinical Psychedelic Research Registered psychiatrists in Louisiana 2025 Survey n = 49
The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample. Nationally representative sample of US adults 2025 Observational cross-sectional study n = 139,524
Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders. International online respondents with current or past experience of psychedelic... 2020 Cross-sectional survey n = 1,102

Explore topics

By condition and practice